Cargando…
Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells
Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MDR) cancer. In the present study, a clinically used synthetic...
Autores principales: | Chang, Ying-Tzu, Teng, Yu-Ning, Lin, Kun-I, Wang, Charles C. N., Morris-Natschke, Susan L., Lee, Kuo-Hsiung, Hung, Chin-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690972/ https://www.ncbi.nlm.nih.gov/pubmed/31406162 http://dx.doi.org/10.1038/s41598-019-48169-2 |
Ejemplares similares
-
Long-term prophylaxis of hereditary angioedema with danazol
por: Xu, Yingyang, et al.
Publicado: (2022) -
Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura
por: Mulroy, E., et al.
Publicado: (2015) -
Corrigendum to: Limited evolutionary conservation of multidrug resistance and collateral sensitivity
por: Apjok, Gábor, et al.
Publicado: (2021) -
Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia
por: Chai, Kern Y., et al.
Publicado: (2019) -
Cyclical Thrombocytopenia Synchronized With the Patient’s Menstrual Cycle Treated With Danazol
por: Menakuru, Sasmith R., et al.
Publicado: (2022)